Skip to main content
. 2022 Dec 16;67:55–61. doi: 10.1016/j.breast.2022.12.008

Fig. 3.

Fig. 3

Acute skin toxicity reported following 26 Gy in 5 fractions to whole breast ( ± sequential boost) during the first week of treatment and weeks 1–4 following treatment for 128 patients treated in the St. Luke's Radiation Oncology Network Dublin Mar–Aug 2020. For patients receiving a boost, week 1 post treatment toxicity occurred one week after completion the boost.